3-aminobenzamide has been researched along with Retinal Degeneration in 2 studies
Retinal Degeneration: A retrogressive pathological change in the retina, focal or generalized, caused by genetic defects, inflammation, trauma, vascular disease, or aging. Degeneration affecting predominantly the macula lutea of the retina is MACULAR DEGENERATION. (Newell, Ophthalmology: Principles and Concepts, 7th ed, p304)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Sahaboglu, A | 1 |
Miranda, M | 1 |
Canjuga, D | 1 |
Avci-Adali, M | 1 |
Savytska, N | 1 |
Secer, E | 1 |
Feria-Pliego, JA | 1 |
Kayık, G | 1 |
Durdagi, S | 1 |
Miki, K | 1 |
Uehara, N | 1 |
Shikata, N | 1 |
Matsumura, M | 1 |
Tsubura, A | 1 |
2 other studies available for 3-aminobenzamide and Retinal Degeneration
Article | Year |
---|---|
Drug repurposing studies of PARP inhibitors as a new therapy for inherited retinal degeneration.
Topics: Animals; Benzamides; Drug Repositioning; Humans; Mice; Phthalazines; Poly(ADP-ribose) Polymerase Inh | 2020 |
Poly (ADP-ribose) polymerase inhibitor 3-aminobenzamide rescues N-methyl-N-nitrosourea-induced photoreceptor cell apoptosis in Sprague-Dawley rats through preservation of nuclear factor-kappaB activity.
Topics: Animals; Apoptosis; Benzamides; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Methyln | 2007 |